PL2707380T3 - Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów - Google Patents

Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów

Info

Publication number
PL2707380T3
PL2707380T3 PL12785572T PL12785572T PL2707380T3 PL 2707380 T3 PL2707380 T3 PL 2707380T3 PL 12785572 T PL12785572 T PL 12785572T PL 12785572 T PL12785572 T PL 12785572T PL 2707380 T3 PL2707380 T3 PL 2707380T3
Authority
PL
Poland
Prior art keywords
hmos
diversification
precursors
human milk
milk oligosaccharides
Prior art date
Application number
PL12785572T
Other languages
English (en)
Inventor
Gyula Dekany
Elise Champion
Andreas Schroven
Markus JONDELIUS HEDEROS
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2012/051314 external-priority patent/WO2012127410A1/en
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL2707380T3 publication Critical patent/PL2707380T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/12Disaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
PL12785572T 2011-05-13 2012-05-14 Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów PL2707380T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11166137 2011-05-13
PCT/IB2012/051314 WO2012127410A1 (en) 2011-03-18 2012-03-19 Synthesis of new fucose-containing carbohydrate derivatives
PCT/IB2012/052401 WO2012156898A1 (en) 2011-05-13 2012-05-14 DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF
EP12785572.4A EP2707380B1 (en) 2011-05-13 2012-05-14 DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF

Publications (1)

Publication Number Publication Date
PL2707380T3 true PL2707380T3 (pl) 2021-01-11

Family

ID=47176364

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12785572T PL2707380T3 (pl) 2011-05-13 2012-05-14 Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów

Country Status (14)

Country Link
US (2) US9382564B2 (pl)
EP (2) EP3744725A1 (pl)
JP (1) JP6106160B2 (pl)
KR (1) KR20140036226A (pl)
CN (1) CN103562214B9 (pl)
BR (1) BR112013029203A2 (pl)
CA (1) CA2835989A1 (pl)
DK (1) DK2707380T3 (pl)
ES (1) ES2820429T3 (pl)
IL (1) IL229047A0 (pl)
MX (1) MX349153B (pl)
PL (1) PL2707380T3 (pl)
RU (1) RU2013155453A (pl)
WO (1) WO2012156898A1 (pl)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013531049A (ja) 2010-07-16 2013-08-01 グリコム アー/エス オリゴ糖の誘導体化
WO2013091660A1 (en) * 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
EP2931737A4 (en) * 2012-12-14 2016-11-16 Glycom As MIXTURE FROM FUCOSYLATE LACTOSES
BR112015025951A2 (pt) * 2013-04-12 2017-10-17 Univ Danmarks Tekniske sialidase mutante com atividade trans-sialidase, para uso em produção de glicanos sialilados
GB201306689D0 (en) 2013-04-12 2013-05-29 Glycom As Synthesis of sialylated/fucosylated human milk oligosaccharides
ES2891731T3 (es) 2013-05-22 2022-01-31 Glycom As Mezcla sintética de oligosacáridos para el tratamiento de la microbiota de un mamífero
EP3041947A4 (en) 2013-09-06 2017-07-26 Glycom A/S Fermentative production of oligosaccharides
EP2857410A1 (en) 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
CN107108677B (zh) * 2014-10-24 2020-08-07 格礼卡姆股份公司 Hmo的混合物
EP3209772A4 (en) 2014-10-24 2018-08-08 Glycom A/S Mutated fucosidase
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20170258820A1 (en) 2014-10-29 2017-09-14 Glycom A/S Synthetic composition and method for promoting mucosal healing
CN115364113A (zh) 2014-10-29 2022-11-22 格礼卡姆股份公司 合成组合物以及用于治疗肠易激综合症的方法
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
CN115350200A (zh) 2014-12-08 2022-11-18 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
EP3277287B8 (en) * 2015-03-31 2023-12-27 Glycom A/S Mixtures of human milk oligosaccharides comprising 3 '-o-sialyllactose
ES2870973T3 (es) * 2015-06-09 2021-10-28 Glycom As Mezclas ternarias de 6'-SL, LNnT y LST c
US10428318B2 (en) 2015-06-09 2019-10-01 Glycom A/S Mutated sialidases
WO2017021476A1 (en) 2015-08-04 2017-02-09 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
PL3349763T3 (pl) 2015-09-14 2022-01-03 Glycom A/S Kompozycja do zastosowania w modulowaniu mikrobioty
EP3368046B1 (en) 2015-10-28 2022-07-27 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
ES2950489T3 (es) 2015-10-28 2023-10-10 Glycom As Composición sintética y método para modular los trastornos de la emoción y del ánimo
WO2017084673A1 (en) 2015-11-17 2017-05-26 Glycom A/S Synthetic Composition for Treating Antibiotic Associated Complications
US11432578B2 (en) 2015-12-15 2022-09-06 Glycom A/S Mixture of HMOs
WO2017144062A1 (en) 2016-02-24 2017-08-31 Glycom A/S Synthetic composition for microbiota modulation
WO2017190754A1 (en) 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea
PL3452051T3 (pl) 2016-05-05 2022-11-14 Glycom A/S Kompozycja zawierająca hmos do zastosowania w leczeniu nadwrażliwości trzewnej i/lub bólu trzewnego mediowanych komórkami tucznymi
US11224605B2 (en) 2016-05-19 2022-01-18 Glycom A/S Synthetic composition
CN109414447A (zh) 2016-06-24 2019-03-01 格礼卡姆股份公司 包括hmo的组合物、其制备和用于预防和/或治疗病毒和/或细菌感染的用途
NZ750365A (en) 2016-07-28 2022-07-01 Fonterra Cooperative Group Ltd Dairy product and process
WO2018157900A1 (en) 2017-03-01 2018-09-07 Glycom A/S Synthetic composition for microbiota modulation
EP3634429A4 (en) 2017-05-09 2020-11-04 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
WO2018215960A1 (en) 2017-05-24 2018-11-29 Glycom A/S Synthetic composition comprising one or more human milk oligosaccharides (hmos)
WO2018215961A1 (en) 2017-05-24 2018-11-29 Glycom A/S Synthetic composition comprising oligosaccharides and its use in medical treatment.
US11142541B2 (en) 2017-06-30 2021-10-12 Glycom A/S Purification of oligosaccharides
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
EP3450443A1 (en) * 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Process for purifying sialylated oligosaccharides
CA3081496A1 (en) 2017-11-02 2019-05-09 Glycom A/S Mixture of hmos for reducing or preventing fatigue
CN111698994A (zh) 2017-11-30 2020-09-22 格礼卡姆股份公司 治疗小麦敏感性的hmo混合物
US11602545B2 (en) 2017-12-05 2023-03-14 Glycom A/S Human milk oligosaccharides for treating migraine
EP3722412A4 (en) * 2017-12-08 2021-11-17 Morinaga Milk Industry Co., Ltd. NEW BIFIDOBACTERIUM, AND COMPOSITION CONTAINING THIS BACTERIA
US11304966B2 (en) 2017-12-22 2022-04-19 Glycom A/S Composition comprising HMOs for preventing or reducing nociception
US11554131B2 (en) 2018-05-31 2023-01-17 Glycom A/S Mixture of HMOs for treating autoimmune diseases
CN113194960A (zh) 2018-12-19 2021-07-30 格礼卡姆股份公司 用于治疗使用低fodmap饮食的人的组合物和方法
CN110016066B (zh) * 2019-04-02 2021-11-02 江西师范大学 一种i型n-聚糖天线的合成方法
CN114350640B (zh) * 2019-12-13 2023-09-08 中国科学院天津工业生物技术研究所 一株表达几丁质酶重组菌的构建及高酶活突变体的筛选
WO2022089707A1 (en) 2020-10-30 2022-05-05 Mille International Aps A method of producing a human milk oligosaccharide (hmo)
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
WO2022223430A1 (en) 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN113960232B (zh) * 2021-10-28 2024-02-20 苏州大学 一种基于唾液特异性岩藻糖基化结构糖谱及其检测方法和应用
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs
WO2024042235A1 (en) 2022-08-25 2024-02-29 Dsm Ip Assets B.V. Hybrid method for producing complex hmos
WO2024110667A1 (en) 2022-11-25 2024-05-30 Dsm Ip Assets B.V. Two-strain system for producing oligosaccharides
DK202201151A1 (en) 2022-12-14 2024-07-02 Dsm Ip Assets B V Mutated lacto-n-biosidase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0586687A4 (en) * 1992-03-25 1996-04-17 Univ New York Trans-sialidase and methods of use and making thereof
JPH0686684A (ja) 1992-05-26 1994-03-29 Monsanto Co シアロ抱合体の合成
US5409817A (en) 1993-05-04 1995-04-25 Cytel, Inc. Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
JPH11503328A (ja) * 1995-04-11 1999-03-26 サイテル コーポレイション オリゴ糖類の改善された酵素合成法
US6323008B1 (en) * 1997-08-14 2001-11-27 Neose Technologies, Inc. Methods for producing sialyloligosaccharides in a dairy source
JP2005500058A (ja) * 2001-08-17 2005-01-06 ネオーズ テクノロジーズ, インコーポレイテッド シアリル化したオリゴサッカリドの化学的酵素的合成
JP5236189B2 (ja) * 2003-12-05 2013-07-17 チルドレンズ ホスピタル メディカル センター オリゴ糖組成物および感染症の治療における該組成物の使用
RU2442438C2 (ru) * 2005-02-21 2012-02-20 Нестек С.А. Смесь олигосахаридов
JP4937288B2 (ja) 2009-03-02 2012-05-23 シャープ株式会社 画像読取装置及び画像形成装置
DE202011111124U1 (de) * 2010-02-19 2020-05-22 Glycom A/S Polymorph eines Tretrasaccharids, das N-Acetyllactosamin enthält
JP2013531049A (ja) 2010-07-16 2013-08-01 グリコム アー/エス オリゴ糖の誘導体化
EP2686330A4 (en) 2011-03-18 2014-11-12 Glycom As SYNTHESIS OF NEW FUCOSE-CONTAINING CARBOHYDRATE DERIVATIVES

Also Published As

Publication number Publication date
IL229047A0 (en) 2013-12-31
WO2012156898A1 (en) 2012-11-22
ES2820429T3 (es) 2021-04-21
MX349153B (es) 2017-07-14
BR112013029203A2 (pt) 2016-08-09
EP2707380B1 (en) 2020-07-08
RU2013155453A (ru) 2015-06-20
US20160289721A1 (en) 2016-10-06
CA2835989A1 (en) 2012-11-22
DK2707380T3 (da) 2020-10-12
EP3744725A1 (en) 2020-12-02
US9382564B2 (en) 2016-07-05
KR20140036226A (ko) 2014-03-25
CN103562214B (zh) 2016-10-19
MX2013013027A (es) 2013-12-02
EP2707380A1 (en) 2014-03-19
EP2707380A4 (en) 2014-10-08
JP6106160B2 (ja) 2017-03-29
CN103562214A (zh) 2014-02-05
JP2014513986A (ja) 2014-06-19
US20140212930A1 (en) 2014-07-31
US9963729B2 (en) 2018-05-08
CN103562214B9 (zh) 2016-12-14

Similar Documents

Publication Publication Date Title
IL229047A0 (en) A shade of oligosaccharides of breast milk or their derivatives
IL229048A0 (en) A method for the production of oligosaccharides of breast milk or their derivatives
EP2779952A4 (en) HAMMER TOE IMPLANT
EP2706936A4 (en) SPECIFIC INSTRUMENTS OF A PATIENT
GB201308746D0 (en) Patient Specific Implants
EP2696800A4 (en) POLYAXIAL DENTAL IMPLANT SYSTEM
EP2781195A4 (en) MEDICAL INSTRUMENT
EP2729080A4 (en) ORTHOPEDIC INSTRUMENTS
ZA201308417B (en) Tissue healing
GB201120345D0 (en) Medical console
EP2739234A4 (en) SURGICAL ASSISTANCE SYSTEM
EP2811928A4 (en) BONE CENTER FOR ELASTIC OSTEOSYNTHESIS
EP2750625A4 (en) REDUCING BIOFILMS ON MEDICAL DEVICES
GB201000916D0 (en) Treatment of biofilms
EP2679140A4 (en) MEDICAL ENDOSCOPE SYSTEM
EP2713914A4 (en) BONE WRIST
GB201118588D0 (en) Device for disinfection of medical devices
EP2713960A4 (en) PATIENT-SPECIFIC INSTRUMENT
EP2742886A4 (en) SURGICAL SYSTEM
EP2692276A4 (en) MEDICAL INSTRUMENT
GB2489312B (en) Medical instrument
IL222328A (en) Tissue microabulation system
EP2543330A4 (en) MEDICAL TRAY
HK1179903A1 (zh) 塗有利莫司的醫療裝置
EP2780051A4 (en) NEW IMPROVED FORMULATIONS FOR COATING MEDICAL DEVICES